Lakefront Biotherapeutics NV Total Assets

Quick Answer

Lakefront Biotherapeutics NV reported Total Assets of $3.41 billion for the year ending 2025.

  • Lakefront Biotherapeutics NV showed a decrease of -17.6% in Total Assets from 2024 to 2025.
  • This data is from Lakefront Biotherapeutics NV's annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), Lakefront Biotherapeutics NV's Total Assets has grown by 669.8%.
  • Historical annual values: Fiscal year 2025: $3.41 billion | Fiscal year 2024: $4.14 billion | Fiscal year 2023: $4.36 billion | Fiscal year 2022: $4.73 billion | Fiscal year 2021: $5.19 billion | Fiscal year 2020: $5.72 billion | Fiscal year 2019: $6.07 billion | Fiscal year 2018: $1.44 billion | Fiscal year 2017: $1.29 billion | Fiscal year 2016: $1.08 billion | Fiscal year 2015: $442.51 million.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: